10.1017/S0007114517001180 127 HeF.ZuoL
GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , leading to reduced caloric intake and weight loss Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus [oral form]), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
APAP-Associated Liver Adaptation Liver adaptation to APAP may occur with therapeutic doses in some individuals
Appetite Control These medications help control appetite, reduce food cravings, and promote healthier eating habits
Together, they may influence processes tied to cell protection, recovery, and adaptive responses
Glutathione c kh nng chng li cc bc x t mi trng bn ngoi tc ng ln da